4 ms·
Ozempic's early success in kidney disease trial drags down dialysis stocks
- gardenfelder 3y agoSeems to relate only to kidney injury from diabetes and weight issues. Need to learn more before making any claims about other forms of CKD.
- InSteady 3y agoThe entire concepts of "dialysis stocks" seems so perverse. I mean, the free market is great and all, but I'm not sure it has a whole lot of societal benefit inside of my damaged organs.
- toomuchtodo 3y agoWarren Buffett can afford the losses (Berkshire owns almost 40% and is the largest institutional investor in DaVita). https://fintel.io/so/us/dva/berkshire-hathaway https://fintel.io/so/us/dva/berkshire-hathaway